Dimensional Fund Advisors LP lowered its position in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 7.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 717,106 shares of the company's stock after selling 60,669 shares during the period. Dimensional Fund Advisors LP owned 1.77% of Phibro Animal Health worth $15,059,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of PAHC. Barclays PLC raised its stake in shares of Phibro Animal Health by 25.7% in the third quarter. Barclays PLC now owns 143,337 shares of the company's stock valued at $3,228,000 after acquiring an additional 29,271 shares during the last quarter. SG Americas Securities LLC raised its position in Phibro Animal Health by 7.4% in the 4th quarter. SG Americas Securities LLC now owns 13,162 shares of the company's stock worth $276,000 after purchasing an additional 906 shares during the last quarter. Inspire Investing LLC bought a new position in Phibro Animal Health in the 4th quarter worth approximately $791,000. Smith Group Asset Management LLC bought a new position in Phibro Animal Health in the 4th quarter worth approximately $541,000. Finally, New York State Teachers Retirement System raised its position in Phibro Animal Health by 16.7% in the 4th quarter. New York State Teachers Retirement System now owns 5,428 shares of the company's stock worth $114,000 after purchasing an additional 775 shares during the last quarter. Institutional investors own 99.34% of the company's stock.
Phibro Animal Health Stock Performance
NASDAQ:PAHC traded up $2.03 during mid-day trading on Monday, hitting $24.50. The stock had a trading volume of 250,068 shares, compared to its average volume of 194,361. Phibro Animal Health Co. has a twelve month low of $16.16 and a twelve month high of $26.55. The stock has a market cap of $992.32 million, a price-to-earnings ratio of 51.04, a PEG ratio of 0.45 and a beta of 0.62. The company's 50 day simple moving average is $19.99 and its 200 day simple moving average is $21.83. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.52 by $0.11. The firm had revenue of $347.80 million for the quarter, compared to analysts' expectations of $352.41 million. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. On average, equities research analysts forecast that Phibro Animal Health Co. will post 1.95 earnings per share for the current year.
Phibro Animal Health Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Wednesday, June 4th will be paid a $0.12 dividend. The ex-dividend date is Wednesday, June 4th. This represents a $0.48 dividend on an annualized basis and a yield of 1.96%. Phibro Animal Health's dividend payout ratio (DPR) is 61.54%.
Analyst Upgrades and Downgrades
Several research analysts recently weighed in on the stock. StockNews.com upgraded shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research report on Friday. Morgan Stanley upped their target price on shares of Phibro Animal Health from $20.00 to $21.00 and gave the company an "equal weight" rating in a research report on Thursday. Finally, Barclays boosted their price target on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an "underweight" rating in a report on Monday, February 10th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $20.00.
View Our Latest Stock Analysis on Phibro Animal Health
Phibro Animal Health Company Profile
(
Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Recommended Stories
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
